A targeted protein assay measures selected peptide signals through a defined workflow. Reliable amounts require evidence about the quantitative range and precision of the assay.
A primary multilaboratory study evaluated isotope-dilution multiple-reaction-monitoring assays for selected plasma proteins, examining recovery, reproducibility, linear range, detection and quantification limits. The performance belonged to the tested materials, analytes and protocols. It was not a universal certificate for all proteins or specimens. A reported protein amount should retain its measured peptide, calibration approach, sample preparation and supported range. An NIH workshop report on targeted mass spectrometry found no consensus on the criteria for a successful peptide assay and set out three tiers of assay performance, with response and calibration curves generated for each analyte in the relevant matrix to establish limits of detection and quantification; quantification rests on precursor-product ion pairs, called transitions, shown to be free of interference, and a surrogate protein standard must be shown to behave like the native analyte in tests of recovery after adding a known amount (Carr and colleagues, 2014). Stable-isotope-labelled internal standard peptides with the sequence of the analyte are spiked into the digest, and extended peptides or recombinant proteins can compensate for variability in digestion (Hoofnagle and colleagues, 2016). A multilaboratory plasma study reported reproducibility, recovery, linear range and limits of detection and quantification at microgram-per-millilitre protein concentrations (Addona and colleagues, 2009).
Shares Tissue preparation and assay suitability, Immune measurements and product evidence.
Shares Reverse-phase protein array (RPPA), Immune measurements and product evidence.
Shares Tissue preparation and assay suitability, Immune measurements and product evidence.
Shares Tissue preparation and assay suitability, Immune measurements and product evidence.
Shares Immune measurements and product evidence, Proteomics & phosphoproteomics.
Shares Reverse-phase protein array (RPPA), Proteomics & phosphoproteomics.
Shares Tissue preparation and assay suitability, Immune measurements and product evidence.
Shares Immune measurements and product evidence, Proteomics & phosphoproteomics.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/